Retinal toxicity during pegylated<i>α</i>‐interferon therapy for chronic hepatitis C: a multifocal electroretinogram investigation

Abstract

Subclinical retinal toxicity during anti-viral therapy with pegylated alpha-interferon and ribavirin was frequent in this study and it suggests that patients should be warned of this risk and monitored during therapy.